Purchase Order SPE2DP24P0361

Award Date 3/19/24
Potential Completion Date 4/3/24
Potential Value $2.2K
Federal Agency
Medical Supply Chain
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Competed under SAP
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Lake Zurich, IL, USA
Solicitation Procedures
Simplified Acquisition
Number Of Offers Received
3
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
The U.S. Defense Logistics Agency (DLA) Troop Support Medical awarded a firm fixed price purchase order contract to Fenwal, Inc., a global blood technology company and subsidiary of Fresenius Kabi. The $2,353.50 contract, awarded on May 30, 2024, is for the delivery of medical supplies and equipment such as washing solutions, diluting solutions, anticoagulants, blood collection assemblies, donor tubing strippers, and other products supporting transfusion medicine and cell therapy applications....
The U.S. Defense Logistics Agency awarded a $2,188.92 firm fixed-price purchase order to Fenwal, Inc., a global blood technology company and subsidiary of Fresenius Kabi. The contract is for the supply of "Washing Solution, FR" to support the agency's medical supply chain operations. This award does not have a set-aside designation. Fenwal has extensive experience providing a wide range of medical supplies and equipment, including blood bags, tubing, solutions, and specialized items,...
This is a firm fixed-price purchase order contract awarded by the Defense Logistics Agency (DLA), a component of the Department of Defense, to Fenwal, Inc., a global blood technology company and subsidiary of Fresenius Kabi. The contract is for the provision of washing solution, which is a specialized medical product used in healthcare and biomedical research applications. The contract has a ceiling value of $11,351.91 and an ultimate completion date of October 17, 2023. Fenwal, Inc. is a...
This federal contract award, number SPE2DP24P0460, was issued by the Defense Logistics Agency (DLA) Troop Support Medical to Fenwal, Inc., a subsidiary of Fresenius Kabi that specializes in blood collection, separation, storage, and transfusion products and services. The $10,300.80 firm-fixed-price purchase order is for the delivery of washing solution, which is likely to support transfusion medicine and cell therapy applications for the Department of Defense and other federal agencies....
This federal contract award, valued at $2,570.40, was issued by the Defense Logistics Agency (DLA) to Fenwal, Inc., a global blood technology company and subsidiary of Fresenius Kabi located in Lake Zurich, Illinois. The contract is a firm fixed-price purchase order for the supply of specialized medical products, such as blood collection assemblies, washing solutions, and apheresis equipment, to support critical healthcare programs, including military medical supply chains, biomedical research...
This is a firm fixed-price purchase order contract awarded by the Defense Logistics Agency (DLA) Troop Support Medical division to Fenwal, Inc., a global blood technology company and subsidiary of Fresenius Kabi. The contract, valued at $1,673.88, is for the supply of washing solution, a medical consumable used in transfusion medicine and cell therapy applications. The contract has an ultimate completion date of May 10, 2024 and was awarded on April 10, 2024 without any set-aside designation....
This federal contract award, with ID SPE2DP23P0467, was issued by the Defense Logistics Agency (DLA) to Fenwal, Inc., a global blood technology company and subsidiary of Fresenius Kabi located in Lake Zurich, Illinois. The $3,510.90 firm fixed-price purchase order is for the supply of washing solution, a specialized medical product used in healthcare and biomedical research initiatives. The contract has no set-aside designation and supports critical defense medical supply chains. Fenwal, Inc. is...
This is a firm fixed-price purchase order awarded by the Defense Logistics Agency (DLA) to Fenwal, Inc., a foreign-owned, for-profit manufacturer of medical equipment and supplies. The contract, valued at $2,691.69, is for the delivery of washing solution, a critical medical consumable. Fenwal, Inc. is a subsidiary of Fresenius Kabi and a registered vendor with the U.S. federal government, having secured numerous contract awards from various agencies including the DLA, National Institutes of...
This federal contract award, valued at $1,426.36, was issued by the Defense Logistics Agency Troop Support Medical to Fenwal, Inc., a global blood technology company and subsidiary of Fresenius Kabi. The contract is for the delivery of various medical supplies and equipment, including blood bags, tubing, solutions, apheresis equipment, and other specialized items used in blood banking and biomedical research operations. The contract does not have a set-aside designation, reflecting Fenwal's...
This federal contract award, valued at $18,378.40, was issued by the Defense Logistics Agency (DLA) to Fenwal, Inc., a global blood technology company and subsidiary of Fresenius Kabi. The contract is for the delivery of various blood collection supplies, including blood collection assemblies, washing solutions, diluting solutions, anticoagulant citrate products, donor tubing strippers, plasma extractors, blood pack sealers, and centrifuging bags. The contract has an ultimate completion date...

This firm fixed-price purchase order contract was awarded by the Defense Logistics Agency (DLA) Troop Support Medical to Fenwal, Inc., a global blood technology company and subsidiary of Fresenius Kabi. The $2,188.92 contract is for the supply of washing solution, FR (flame retardant) to support federal agencies such as the Department of Defense, Department of Veterans Affairs, and National Institutes of Health. Fenwal has a long history of providing a wide range of medical supplies and equipment, including blood bags, tubing, solutions, apheresis equipment, and specialized consumables for transfusion medicine and cell therapy applications. This contract, which has an ultimate completion date of April 3, 2024, does not have a set-aside designation, reflecting Fenwal's capabilities in this specialized field. The company's federal contract awards have enabled it to consistently support critical healthcare and research initiatives across various U.S. government agencies.

Generated 7/28/24, 9:37 AM